17-estradiol (E2) retards/prevents the development and progression of glomerulosclerosis (GS) in female mice, a disease process, which is largely determined by, age, genetic traits, and sex. E2 exposure maintains glomerular cells in an estrogen responsive/sensitive state. Prolonged estrogen deficiency leads to estrogen unresponsiveness at which time E2 replacement no longer reduces GS. It is generally accepted that aging is associated with an increase in oxidant stress (OS), which promotes age-related diseases especially in the cardiovascular/renal systems, including the glomerulus. Another feature of aging in female individuals is the loss of E2-mediated cardiovascular/renal protection. Mitochondria are a major source of reactive oxygen species (ROS), and the production and action of ROS can be modulated by E2. Based on new preliminary data, we hypothesize that E2 action modulates OS, which directly affects maintenance or deterioration of glomerular structure and function. We postulate that (i) OS increases in states of and/or as a result of E2 deficiency which promotes the development and progression of GS during aging, (ii) E2 replacement after prolonged periods of estrogen deficiency fails to reverse or prevent progression of GS because of the lost ability of E2 to restore its protective effects against OS in glomerular cells, and (iii) E2-mediated actions modulate mitochondrial respiration, oxidative phosphorylation, apoptosis and retrograde signaling pathways. We propose the following Specific Aims to test this hypothesis:
Aim I, Determine whether OS diminishes estrogen-mediated protection in mesangial cells and podocytes during aging;
Aim II, Determine if estrogen action modulates mitochondrial oxidative phosphorylation, respiration, apoptosis and retrograde signaling in mesangial cells and podocytes during aging.
Aim III, Determine whether glomerular-cell specific deletion of ERa in young female B6 mice leads to GS similar to that seen in aging and whether OS plays a role in vivo.

Public Health Relevance

Age-associated renal disease presents an important health problem, since 11% of those 65 years or older have decreased renal function, even when corrected for hypertension and diabetes mellitus. Estrogen deficiency contributes to the development of renal disease in aging women. This proposal will elucidate the role of the age-related decrease of estrogen action and the increase of oxidant stress in the development of renal disease in aging women.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Project (R01)
Project #
Application #
Study Section
Aging Systems and Geriatrics Study Section (ASG)
Program Officer
Fuldner, Rebecca A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Miami School of Medicine
Schools of Medicine
Coral Gables
United States
Zip Code
Doublier, Sophie; Lupia, Enrico; Catanuto, Paola et al. (2011) Estrogens and progression of diabetic kidney damage. Curr Diabetes Rev 7:28-34
Doublier, Sophie; Lupia, Enrico; Catanuto, Paola et al. (2011) Testosterone and 17ýý-estradiol have opposite effects on podocyte apoptosis that precedes glomerulosclerosis in female estrogen receptor knockout mice. Kidney Int 79:404-13
Linder, Jessica M; Pincus, David J; Panthaki, Zubin et al. (2009) Congenital anomalies of the hand: an overview. J Craniofac Surg 20:999-1004
Elliot, S J; Berho, M; Korach, K et al. (2007) Gender-specific effects of endogenous testosterone: female alpha-estrogen receptor-deficient C57Bl/6J mice develop glomerulosclerosis. Kidney Int 72:464-72
Karl, Michael; Berho, Mariana; Pignac-Kobinger, Judith et al. (2006) Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivo. Am J Pathol 169:351-61
Elliot, Sharon J; Karl, Michael; Berho, Mariana et al. (2006) Smoking induces glomerulosclerosis in aging estrogen-deficient mice through cross-talk between TGF-beta1 and IGF-I signaling pathways. J Am Soc Nephrol 17:3315-24
Karl, Michael; Potier, Mylene; Schulman, Ivonne H et al. (2005) Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells. Endocrinology 146:889-900
Feng, Zheng; Plati, Anna Rita; Cheng, Qing-li et al. (2005) Glomerular aging in females is a multi-stage reversible process mediated by phenotypic changes in progenitors. Am J Pathol 167:355-63
Zheng, Feng; Cornacchia, Flavia; Schulman, Ivonne et al. (2004) Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow: the role of mesangial cell progenitors. Diabetes 53:2420-7
Zheng, Feng; Cheng, Qing-Li; Plati, Anna-Rita et al. (2004) The glomerulosclerosis of aging in females: contribution of the proinflammatory mesangial cell phenotype to macrophage infiltration. Am J Pathol 165:1789-98

Showing the most recent 10 out of 18 publications